Tag Directory / PUBLICHEALTH     showing 1–5 of 5   RSS


for: Saturday, July 04, 2026



A child can drown in seconds. Doctors want more families to be prepared

medicalxpress - Doctors and others are sounding an alarm: More U.S. children have been drowning in recent years.

AI Summary: Toddlers can slip beneath the surface faster than anyone expects; clinicians are urging families to stop assuming “it won’t happen to us.” They recommend constant supervision near water, basic CPR training, secure barriers, life jackets for non-swimmers, and wider public education to prevent rapid, often silent drowning incidents. Practical steps save lives—no heroics required.

2 days / medicalxpress

6 days / medicalxpress

7 days / abcnews




The US is hooked on unregulated peptides. But are they effective, or even safe?

livescience - The world of peptides has exploded in wellness circles, but the benefits of injecting these gray-market molecules rest on little clinical evidence.

AI Summary: Unregulated peptide products have proliferated in the US, raising safety and efficacy concerns as federal regulators convene a contentious panel that includes proponents of these off‑label compounds. The debate highlights a market gap where hype often outpaces evidence — and where regulators must decide whether to tidy up the wild west or watch it fester.

4 days / medicalxpress

7 days / livescience

9 days / medicalxpress

11 days / abcnews




Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine

Frank Vinluan / medcitynews - FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a stan…

AI Summary: Orca Bio’s off‑the‑shelf allogeneic cell therapy received FDA approval, marking a milestone for engineered living medicines. Regulators cleared the product after pivotal efficacy and manufacturing data, offering broader access to cellular therapy but spotlighting cost, supply logistics and the need for robust post‑market safety surveillance.

2 days / medicalxpress

8 days / oncodaily




'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial

medicalxpress - A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers sho…

AI Summary: The POLY‑HF randomized trial found that a fixed‑dose 'polypill' for heart failure with reduced ejection fraction cut hospitalizations and emergency visits by roughly 60%, improving adherence and standardizing therapy. Results suggest a pragmatic, low‑complexity intervention could deliver substantial health‑system benefits if adopted broadly and monitored for implementation challenges.

8 days / medicalxpress




CDC urges people to prevent mosquito bites as West Nile virus season hits a strong, early start

medicalxpress - Health officials are encouraging people to use bug spray and mosquito-control efforts as West Nile virus season is off to its earliest and worst start in over two decades.

AI Summary: The CDC issued an early‑season alert as West Nile virus activity ramps up, urging repellents, removal of standing water and extra protection for older or immunocompromised people. Public‑health teams are intensifying surveillance while reminding the public that simple preventive measures remain the best defense against local transmission.

4 days / bbc

9 days / medicalxpress

9 days / abcnews




Back to Top


PUBLICHEALTH Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Reproductive Health, Product Recall, Vaccine Safety, Zoonotic Disease and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.